Chauche Thierry 4
4 · Sagimet Biosciences Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Sagimet (SGMT) CFO Thierry Chauche Sells 1,312 Shares
What Happened Thierry Chauche, Chief Financial Officer of Sagimet Biosciences (SGMT), sold 1,312 shares on February 10, 2026 at $5.36 per share, for proceeds of about $7,033. The filing (Form 4) was submitted on February 12, 2026. This transaction is a sale (routine) rather than a purchase.
Key Details
- Transaction date: 2026-02-10; Filing date: 2026-02-12 (appears timely under Form 4 rules).
- Price and size: 1,312 shares sold at $5.36 per share; total ≈ $7,033.
- Transaction type: Sale (code S); footnote indicates tax-withholding sale related to RSU vesting (automatic, not discretionary).
- Footnote: "Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units."
- Shares owned after transaction: Not specified in the provided excerpt.
Context This sale was executed to satisfy tax withholding on vested restricted stock units (RSUs). Such automatic withholding sales are common and are administrative in nature, not necessarily an indicator of the insider’s view on the company’s prospects.
Insider Transaction Report
Form 4
Chauche Thierry
Chief Financial Officer
Transactions
- Sale
Series A Common Stock
[F1]2026-02-10$5.36/sh−1,312$7,033→ 15,688 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact|2026-02-12